HomeQuestion
Do you offer adjuvant chemotherapy to patients with urachal adenocarcinoma and at least one high risk feature?
1 Answers
Mednet Member
Medical Oncology · Hematology-Oncology Associates of Fredericksburg, Inc.
In the absence of data in this space, I would offer adjuvant chemotherapy applying similar principles from colon adenocarcinoma for patients with T4 or node positive disease. FOLFOX/CAPOX for 3 to 6 months is reasonable in this situation. This regimen has the most reliable and reproducible data in t...